Lyvgen Biopharma
PrivateLast Round
Series C
Feb 23, 2021
Total Funding Raised
$30M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lyvgen Biopharma is a biotechnology company that develops novel immuno-oncology (IO) agonist antibodies for cancer therapy using its proprietary xLinkAb platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lyvgen Biopharma Comparables
Compare Lyvgen Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pyxis Oncology | 79% | |
| Adagene | 78% | |
| Alligator Bioscience | 77% |
Lyvgen Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 23, 2021 | ||||
| Series B | Jul 16, 2018 | ||||
| Series A | May 5, 2016 |
Lyvgen Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series C |
| Morningside Ventures | Series B, Series A |
| Chengwei Capital | Series C |
| 6 Dimensions Capital | Series B |
| Shanghai Free Trade Zone Fund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 689% MoM, reaching 2.7K.
- Jul 26, 2026
Monthly visitors increased 1104% MoM, from 28 to 337.
Lyvgen Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lyvgen Biopharma's valuation, stock price, and market status.
Is Lyvgen Biopharma a public or private company?
Lyvgen Biopharma is a private company.
What is the current stock price of Lyvgen Biopharma?
Lyvgen Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Lyvgen Biopharma worth (valuation)?
Valuation information for Lyvgen Biopharma is not publicly available.
Can I buy Lyvgen Biopharma stock?
Lyvgen Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lyvgen Biopharma's last funding round?
Funding round information for Lyvgen Biopharma is not publicly available.
Who are the main investors in Lyvgen Biopharma?
Investor information for Lyvgen Biopharma is not publicly disclosed.
Will Lyvgen Biopharma IPO soon?
No public IPO plans have been announced for Lyvgen Biopharma.
How can I track Lyvgen Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lyvgen Biopharma's secondary market activity and sign up for updates.